IP Library Granted Patent US 9,895,379
Granted Patent B2
US 9,895,379 · App. 14/885,488 · Granted Feb 20, 2018

17alpha, 21-dihydroxypregnene esters as antiandrogenic agents

Inventors: Mauro Ajani (Lainate, IT); Luigi Moro (Cairate, IT)
Assignee: CASSIOPEA S.P.A.
A61K31/573A61K9/0014A61K9/06A61K9/127A61K47/06A61K47/10A61K47/12A61K47/14A61K47/20C07J5/0053C07J9/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,895,379
App. No.
14/885,488
Granted
Feb 20, 2018
Kind
B2
Abstract

The present application provides 17 and/or 21 esters of 17α,21-Dihydroxypregna-4,9(11)-diene-3,20-dione and 17α,21-dihydroxypregna-4-ene-3,20-dione having remarkable antiandrogenic activity, methods of using these compounds, and processes for their preparation.

Claims (22)

1. A method of preparing a compound according to formula II:

wherein R 2 is a C 3 -C 18 acyl group, the method comprising:

selectively esterifying a compound of Formula III

to give a compound of Formula IV

wherein R 1 is an alcohol protecting group capable of being removed with a palladium catalyst;

esterifying the compound of Formula IV to give a compound of Formula V

and;

selectively deprotecting the compound of Formula V to give the compound of Formula II.

2. The method of claim 1 , where R 2 is —C(O)CH 2 CH 3 .

3. The method of claim 1 , wherein R 1 is allyloxycarbonyl or benzyloxycarbonyl.

4. The method of claim 1 , wherein selectively esterifying a compound of Formula III to give a compound of Formula IV comprises reacting the compound of Formula III with allyloxycarbonyl chloride, benzyloxycarbonyl chloride, or tert-butylcarbonyl chloride.

5. The method of claim 4 , wherein the reacting takes place in a solvent at from −5° C. to 40° C.

6. The method of claim 5 , wherein the solvent is dimethylformamide or isobutene.

7. The method of claim 1 , wherein esterifying the compound of Formula IV to give a compound of Formula V comprises reacting the compound of Formula IV with a carboxylic acid anhydride in the presence of a catalyst.

8. The method of claim 7 , wherein the catalyst is 4-dimethylaminopyridine.

9. The method of claim 1 , wherein esterifying the compound of Formula IV to give a compound of Formula V comprises reacting the compound of Formula IV with a carboxylic acid in the presence of a carbodiimide.

10. The method of claim 9 , wherein the carbodiimide is dicyclohexylcarbodiimide.

11. The method of claim 1 , wherein esterifying the compound of Formula IV to give a compound of Formula V comprises reacting the compound of Formula IV with an active ester.

12. The method of claim 11 , wherein the active ester is a trifluoroethyl active ester, an N-acylphthalimide active ester, or an N-acylbenzotriazole active ester.

13. The method of claim 1 , wherein selectively deprotecting the compound of Formula V comprises reacting the compound of Formula V with a palladium catalyst.

14. The method of claim 13 , wherein the palladium catalyst is tetrakis(triphenylphosphine) palladium.

15. The method of claim 13 , reacting the compound of Formula V with a palladium catalyst takes place in dichloromethane or tetrahydrofuran.

Assignments (3)
CHANGE OF NAME Recorded Nov 14, 2017
From: COSMO DERMATOS SRL.
To: CASSIOPEA S.P.A.
Reel/Frame 044443/0886 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2017
From: COSMO S.P.A.
To: COSMO DERMATOS SRL.
Reel/Frame 044123/0033 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2017
From: AJANI, MAURO; MORO, LUIGI
To: COSMO S.P.A.
Reel/Frame 044395/0737 →
Priority Claims (1)
IT MI01A1762 · Aug 10, 2001 · national
Continuity (6)
Continuation 14174765 · Sep 2, 2014
Continuation 14103707 · Dec 11, 2013
Continuation 13398222 · Feb 16, 2012
Continuation 12457870 · Jun 24, 2009
Division 10486386
Related Publication 20160263127A1 · Sep 15, 2016